A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
收藏DataCite Commons2026-04-29 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00013054/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to demonstrate superiority of treatment with avelumab versus continuation of first-line chemotherapy.
提供机构：
Vivli
创建时间：
2026-04-29
